Home / Intelligence / Webinars / Enabling Contracting Capabilities: Uncovering the What, When and How
Available On Demand
Is your company planning to begin commercial contracting or preparing to contract within a new channel?
If you are a leader in a pre-commercial or commercial emerging life sciences company facing these challenges, this webinar is designed for you.
Join our experts from TGaS Advisors, a division of Trinity Life Sciences, as we share what you need to know whether you are embarking on your commercial contracting journey or thinking about a new contracting channel such as payer contracting, provider contracting, specialty, etc.
Key Webinar Topics
- What capabilities need to be enabled for each of the typical Pricing & Contracting functions: Strategic Pricing & Contract Strategy, Proposal Development & Analytics, Government Pricing & Compliance, and Contract Administration?
- When should activities be implemented according to our contract readiness timeline?
- How should capabilities be enabled based on industry best practices?
- What are the seven keys to success?
Featuring
Dmitry Kublanov
Vice President,
Pricing, Contracting and Analytics
Justin Wutti
Director,
Pricing, Contracting and Analytics
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Blog
Rise with the waves: France – Accelerating Pricing and Market Access: Two Policies Shaping Pharma’s Future
Executive Summary The latest publication of new reimbursement regulations in the French Social Security Financing Act (PLFSS 2024), coupled with the recent approval of HEMGENIX® through the direct access scheme in France this past December, underline continued efforts in France to innovate its healthcare system. The 2024 PLFSS emphasizes: The direct access scheme is expected […]
Read More
Webinars
2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility
May 1, 2024 | 12:00 – 12:45 PM ET / 18:00 – 18:45 CET
An additional session will be offered on May 7th at 16:00-16:45 (UTC+8:00) – Asia/Shanghai How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for […]
Sign Up Now
Blog
Rise with the waves: Canada – A Coming (R)evolution: Transforming Pharmaceutical Market Access
Executive Summary Canada has undertaken meaningful strategies to transform patient access and ultimately improve health outcomes across the country. Two such potentially high-impact strategies include the planned transformation of the former Canadian Agency for Drugs and Technology in Health (CADTH) into the new Canadian Drug Agency (CDA) over the course of the next five years, […]
Read More